(UPDATE) Ixazomib
Selinexor
(UPDATE) Daratumumab
Elotuzumab
NCCN Virtual Reimbursement Resource Room
National Cancer Institute (NCI) - Supported Cancer Clinical Trials
ASCO: COVID-19 Medical Resources
International Myeloma Foundation (IMF)